TrialJournal of nuclear medicine : official publication, Society of Nuclear Medicine2015

Increased permeability-glycoprotein inhibition at the human blood-brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar.

William C Kreisl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.